Answers are grounded in this paper and cite their sources.
Combination antihypertensive therapies, particularly those with complementary modes of action, are often necessary to achieve blood pressure goals and must be tailored to patient comorbidities.
SUMMARY Renin–angiotensin system inhibitors, calcium channel blockers and diuretics are the mainstay of current antihypertensive therapy. Patient characteristics are likely to influence the individual response to these agents, although the majority of patients require dual therapy to meet blood pressure goals and some require triple therapy. Combination therapies offer effective blood pressure reductions, particularly when combining therapies with complementary modes of action, and may reduce side-effect burden. Typically, patients who require combination therapy will have comorbidities that influence the preferred antihypertensive class for their treatment. Single-pill combinations can offer practical benefits, but lack dose flexibility and may not comprise drug classes that are optimal for a specific patient. The management of patients who require multiple therapies, therefore, involves weighing the benefits of convenience against the need to select therapies based on a consideration of therapeutic indi...
No takes yet. Share an insight, caveat, or question.
Joel M. Neutel (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: